Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004666242 | SCV005157112 | uncertain significance | Inborn genetic diseases | 2024-04-20 | criteria provided, single submitter | clinical testing | The c.110A>G (p.Y37C) alteration is located in exon 3 (coding exon 2) of the SGPL1 gene. This alteration results from a A to G substitution at nucleotide position 110, causing the tyrosine (Y) at amino acid position 37 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |